AI Science Tracker
EN

Comparative evaluation of ResNet-Based AI models for breast cancer detection in digital mammography and digital breast tomosynthesis

Department of Allied Medical Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology · 10 Nov 2026 · medicine

Discovery

Comparative evaluation of ResNet-Based AI models for breast cancer detection in digital mammography and digital breast tomosynthesis

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: ResNet-18/50 compared on 681 images/391 cases with patient-level splitting, 10-fold CV and a separate external set (73 normal and 6 abnormal images); internal AUCs are high, but external sample is small. Compared with active record 2020-01-screening-seno (large UK/US cohorts and a different screening system), this article uses a separate 391-case DM/DBT dataset and ResNet architecture; no same-result identity.

Technology: ResNet-18 and ResNet-50

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ResNet-18 and ResNet-50 is used in the reported analysis or evaluation.
Limitation / still unknown
The study uses 391 cases and a small external set (73 normal and 6 abnormal images); broader screening performance is not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/systems-biology/articles/10.3389/fsysb.2026.1921782/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.